ODDO BHF Asset Management’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
Other funds holding RNAM
ODDO BHF Asset Management's RNAM Position: Q1 2026 in Review
ODDO BHF Asset Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 377,500 shares — an estimated $27.2M sold.
ODDO BHF Asset Management first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $27.2M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.
- ODDO BHF Asset Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
- ODDO BHF Asset Management sold 377,500 Avidity Biosciences shares in Q1 2026, an estimated $27.2M.
- ODDO BHF Asset Management first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
- ODDO BHF Asset Management's Avidity Biosciences position peaked at $27.2M in Q4 2025.
- 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.
Based on ODDO BHF Asset Management's 13F filing for Q1 2026, filed 18 May 2026.